Illumina inc stock.

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022. Nov 3, 2022. Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis. GAAP diluted loss per share of $ (24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 ...

Illumina inc stock. Things To Know About Illumina inc stock.

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. ("Illumina" or the "Company") . Such investors are advised to contact ...Tracfone Wireless Inc has been a leading player in the telecommunications industry, offering innovative solutions and cutting-edge technology to its customers. With a focus on providing reliable and affordable wireless services, Tracfone ha...Nov 13, 2023 · Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 15.2% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $248.87 and as low as $89.00. Year to date, Illumina, Inc.’s stock ... Jan 7, 2013 · SAN DIEGO--(BUSINESS WIRE)--Jan. 7, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone ...

Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.Illumina, Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: ILMN | Nasdaq

EPS: -$4.77 in Q3 vs. -$24.26 in the same period last year. Excluding items, Illumina Inc. reported adjusted earnings of $52 million or $0.33 per share for the period. Analysts projected $0.12 per ...Illumina, Inc. ILMN stands as a dominant force in the genomics industry, providing integrated systems for the analysis of genetic variation and biological function. Since its inception, Illumina has made significant contributions to the fields of life sciences and clinical research through its innovative sequencing and array-based solutions for ...

Illumina Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ILMN updated stock price target summary.17 equities research analysts have issued 1 year price targets for Illumina's shares. Their ILMN share price targets range from $100.00 to $328.00. On average, they predict the company's share price to reach $194.56 in the next year. This suggests a possible upside of 77.2% from the stock's current price.The low in the last 52 weeks of Illumina stock was 89.01. According to the current price, Illumina is 122.47% away from the 52-week low. What was the 52-week high for Illumina stock?Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Weaker Guidance Dragged Illumina (ILMN) in Q3. (Insider Monkey) Nov-16-23 04:50PM. Illumina: Company Investigated by the Portnoy Law Firm. (GlobeNewswire) 10:15AM. Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors.

Illumina Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ILMN updated stock price target summary.

U.S. genetic testing company Illumina was fined a record 432-million-euro ($476 million) by the EU on Wednesday for closing its takeover of cancer test maker Grail before securing EU antitrust ...

GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 ...Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $28.30. Hence, Illumina's PS Ratio for today is 3.55. Good Sign: Illumina Inc stock PS Ratio (=3.6) is close to 10-year low of 3.33. The historical rank and industry rank for Illumina's PS Ratio or its related term are showing as below:You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Detailed Financial Results for Illumina. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Please reach out to our Investor Relations team at [email protected] if you have questions.Nov 29, 2023 · Stock Information. View current and historic stock prices, analyst information, and more. Financial Information. Download quarterly earnings reports, supplementary data, SEC filings, and more. Corporate Governance. Learn about our governance guidelines, code of ethics, Board of Directors, and more.

Jul 12, 2023 · Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57. If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Illumina, Inc. (ILMN) Stock Price, Quote, News & Analysis ILMN Illumina, Inc. Stock Price & Overview 62.97K followers $101.95 0.38 ( +0.37%) 4:00 PM 11/30/23 …Find the latest Illumina, Inc. (ILMN) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Nov 30, 2023 · Illumina Inc (ILMN) is a leading provider of tools and services for genetic analysis and sequencing. The stock price, news, and analysis of ILMN are updated daily on Morningstar, including its rating, valuation, sustainability, and performance. See how ILMN compares to its competitors and the healthcare industry. NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN). …Mar 13, 2023 · SAN DIEGO, March 13, 2023 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for ...

Jun 9, 2023 · Illumina, Inc. price | Illumina, Inc. Quote. GRAIL continues to witness demand from consumers, physicians, health systems and payers. GRAIL revenues of $20 million in the first quarter grew 100% ...

Get the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings date, dividend yield, market cap and more. SAN DIEGO, March 27, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing (NGS) data.Illumina, Inc. stock has a Value Score of 11, Growth Score of 90 and Momentum Score of 14. Comparing Waters Corporation, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Contact Email [email protected]. Phone Number 858.202.4500. Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions ...Nov 30, 2023 · Illumina Inc.’s stock growth can be attributed to the overall success of the stock market, with the S&P 500 Index and the Dow Jones Industrial Average experiencing positive movements. The company’s consecutive days of gains and increased trading volume also indicate growing investor interest. Nov 24, 2023 · Grading Illumina, Inc. Stock. Before you choose to buy, sell or hold Illumina, Inc. stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement.

October 11, 2023. SAN DIEGO, Oct. 11, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) posted a stewardship-focused presentation for investors on the Events & Presentations section of its investor relations website, investor.illumina.com, on Wednesday, October 11, 2023. Members of Illumina's Board of Directors and senior …

Illumina Inc (ILMN) Stock Shows Positive Performance and Potential for Growth, Analysts Predict. On September 6, 2023, Illumina Inc (ILMN) stock was performing well, with analysts predicting a positive future for the company. The 20 analysts offering 12-month price forecasts for ILMN had a median target of $207.50, indicating a …

SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms. This partnership accelerates the rapidly …Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.400.0049 or +1.323.794.2149 outside North America, both with Conference ID 1991305.Feb 7, 2023 · Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis. Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $28.30. Hence, Illumina's PS Ratio for today is 3.55. Good Sign: Illumina Inc stock PS Ratio (=3.6) is close to 10-year low of 3.33. The historical rank and industry rank for Illumina's PS Ratio or its related term are showing as below:At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Get the latest Illumina, Inc. (ILMN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected] innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325

See Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.SAN DIEGO, March 13, 2023 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for ...Illumina Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ILMN updated stock price target summary.Instagram:https://instagram. nsrgy dividendgenerac competitorshome building stocksameritrade short selling fees Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. how much money for a gold barauto trading websites Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance factset analyst reports On June 11, the gene sequencing giant Illumina ( ILMN 3.87%) announced that its CEO, Francis deSouza, resigned after a tenure of roughly 10 years and that the company would start looking for a ...Date. Title. Nov 14, 2023. Illumina To Webcast Upcoming Investor Conferences. Nov 13, 2023. Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries. Nov 9, 2023. Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023. View All Press Releases.Interactive Chart for Illumina, Inc. (ILMN), analyze all the data with a huge range of indicators.